![Regorafenib Catalog No.:M10913-10 Chemical Name: 2-({1-[13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M10913_1621562681.gif?v=1621562683)
Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Chemical Name: 2-({1-[13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6
AZM475271 suppresses tumor growth and metastasis in vitro and in vivo potentially by anti-angiogenic mechanisms
Isopentyl 4-methoxycinnamate
PubMed PMID: 26993765
Formula: C4H3FN2O2
Regorafenib Catalog No.:M10913-10 Chemical Name: 2-({1-[13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6Regorafenib, also known as BAY 73 4506 ; is a n orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. Regorafenib demonstrated to increase the overall survival of patients with metastatic
US$ 138.62
US$ 22.00
US$ 132.82
US$ 125.00
US$ 193.00
US$ 15.00
US$ 16.00
US$ 15.00